Company news
SKRR Exploration, Inc. news in 2006
SKRR Exploration, Inc.'s news releases, calls and decks from 2006, newest first.
Biomira announces U.S. $13 million financing
December 13, 2006
Biomira receives special protocol assessment from the FDA for Phase III trial of Stimuvax for non-small cell lung cancer
December 12, 2006
Biomira Inc. announces third quarter 2006 results
November 2, 2006
Biomira Announces Acquisition of ProlX Pharmaceuticals
October 31, 2006
Biomira Inc. Announces U.S. $100 Million Shelf Registration
September 27, 2006
Biomira Appoints Robert Kirkman President and CEO
August 30, 2006
Biomira Inc. Announces Second Quarter 2006 Results
July 27, 2006
Biomira Stimuvax(R) (L-BLP25) Prostate Cancer Study Results Published
July 20, 2006
Biomira Retains Janney Montgomery Scott to Explore Pipeline Development Options
June 20, 2006
Dr. Alex McPherson Steps Down from Biomira's Board of Directors
June 1, 2006
Biomira Board appoints Edward A. Taylor to Board of Directors
May 18, 2006
Biomira to web cast 2006 Annual General Meeting
May 16, 2006
Phase 2a results in ovarian cancer reported by Biomira's commercialization partner Prima BioMed
May 16, 2006
Biomira Inc. - Annual General Meeting Webcast - May 17, 2006
May 15, 2006
Biomira announces final Phase 2b survival results of Stimuvax(R) (formerly known as BLP25 Liposome Vaccine) trial in patients with non-small cell lung cancer
April 28, 2006
Biomira Inc. announces first quarter 2006 results
April 27, 2006
Dr. Alex McPherson Steps Down as President and CEO of Biomira
April 3, 2006
Biomira Inc. announces year-end results
March 9, 2006
Biomira completes U.S. $16.07 million financing
February 8, 2006
Biomira President & CEO to Participate in Cancer Immunotherapy Focus Session at BIO CEO & Investor Conference
February 8, 2006
Biomira announces U.S. $16.1 million financing
January 27, 2006
Conference call replay information - Biomira Inc.
January 26, 2006
Biomira Inc. announces amendment to licensing agreement for BLP25 Liposome Vaccine
January 26, 2006